TrialDrug design, development and therapy2019

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates.

Scott A Reisman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.